- A review on NICE’s HTA methodologies has been released, including review on quality of life measures
- NICE acknowledges the greater use of ‘data analytics and real-world evidence’ could play a part in how it might revise its methodologies.
- The aim is to support faster access to new technologies for patients
Click here to read the source article
SVMPharma: driving the outcomes that matter with RWE studies leading to positive HTA submissions and value based outcomes.
SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.